Statistical considerations in the establishment of release criteria for allergen vaccines in the USA.
Slater
J E
JE
Laboratory of Immunobiochemistry, Division of Allergenic Products and Parasitology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD, USA.
Gam
A A
AA
Solanki
M D
MD
Burk
S H
SH
May
F M
FM
Pastor
R W
RW
D000485:Allergens / Q000009:adverse effects / Q000276:immunology*; D004335:Drug and Narcotic Control; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D011506:Proteins / Q000032:analysis; D014481:United States; D014612:Vaccines / Q000009:adverse effects / Q000276:immunology*
D000485:Allergens; D011506:Proteins; D014612:Vaccines